U.S. Markets close in 5 hrs 16 mins

Acorda Therapeutics, Inc. (ACOR)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.33+0.12 (+0.65%)
As of 10:44AM EDT. Market open.
People also watch
AMAGALNYACADBMRNSGEN
  • Nice bounce this morning. If this trend continues,
    I'm expecting short interest to be lowered by approx 1MM shares by EOD tomorrow.
  • You might want to look at NDRM. Way more efficient on off time. It will eat ACOR lunch. There will not even be many off times since it is 24 hr liquid delivery. In other words....ACOR really has no new drugs. Acor may sell peak 100 mill a yr as it will be nice as protective maintenance for some patients.
  • Old news! Already price in...
  • Jumped up as high as 19.90 AH ( poor guy ! ) then tumbled all the way back to 16.50 quickly ..

    Buying w/o really knowing why it looks like.
  • Your take on the latest news, released 16 hours ago? They could have packaged it with the news released two days ago. Is the ACOR management too desperate hoping to get noticed by 'shouting': barrage of priced in old news repackaged all the same?
  • BLOCKBUSTER DRUG !!!!!!!!!!!!! $40 IS IMMINENT BUY BUY BUY. WILL EXPLODE
  • SHORTS BETTER COVER YOUR POSITION , MONDAY WILL BE HUGE GAP UP
  • ACOR is up 8.85% to 16.60
  • Obstacles are those frightful things you see when you take your eyes off the goal. http://dataunion.tistory.com/13178

    Nuveen Diversified Dividend _a NYSE $JDD Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is 0.4 In other words, the correlation coefficient of the other stocks
    dataunion.tistory.com
  • buying AXSM at $4 is like buying JAZZ at $1 a few years ago now trading at $151
    (AXSM) Market Cap $90 M/Cash $55 M / 5x BIG Phase 3 programs in various indications targeting large Markets with first results in Q3 2017 =20 BAGGER ..FANTASTIC OPPORTUNITY !

    Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $90 million and $55 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .

    This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL

    Axsome (AXSM)

    Market-Cap: $90 Million
    Cash: $55 Million(cash runway into the first quarter of 2019.)
    Price:$3.90

    Shares Out: 23.5 Million

    Aegis Capital has reiterated a ‘Buy’ rating and price target of $20 on Axsome Therapeutics (NASDAQ: AXSM) after the company reported financial results for the quarter ended March 31, 2017. The analyst noted that although Axsome reported revenue in-line with consensus estimates, the focus remains on upcoming catalysts such as the company’s ongoing clinical trials. Since February 2017, the company’s AXS-05 has received fast track designation from the FDA for the treatment of Alzheimer’s disease (AD) agitation and treatment resistant depression (TRD). Topline data from the TRD treatment study is expected in the first quarter of 2018. Additionally, Axsome is developing AXS-02 in three separate phase 3 clinical programs, including chronic low back pain associated with modic changes and complex regional pain syndrome, with interim data expected in the fourth quarter of 2017, as well as knee osteoarthritis associated with bone marrow lesions, with interim data expected in the third quarter of 2017.
  • It would be interesting to see IF Biogen changes their relationship with ACOR and just buys them, now that ACOR's market cap has dropped. Biogen pays royalties to Acorda on outside U.S. sales. Fampyra royalties were $2.5 million, flat year over year.
    So............ it seems to me that ACOR is having trouble executing sales here in the US.
    Thoughts??
  • They loss their patent or rights to frampiline , buy now the Parkinson drug has favorite results and is up to 16.76 ah.
  • Bail in pre market @ 5am . My charts and the quants I run say this is heading to 14 at least. You made some good money from the bio tech darling of the day, move on to your next winner. Don't forget, pigs get fed, hogs get slaughtered. See you @ 14 at by days end, maybe lower. Don't forget to tip your waitress.....
  • ACOR is up 8.82% to 16.65
  • It should go to 20.00 or higher , this is big news with very good results.
  • If u listen to Pumper Cathy, u will end up like broke, living & playing in your parents basement. You don't want to end up like Cathy do u? Keep pumping Cathy! Lol.....
  • WOW GOING TO $40 NEXT WEEK !!!!!!!!!!!
  • GAP UP BIG TIME TOMORROW !!!!!!!!OVER $20 easy
  • WILL BE BOUGHT AT $40 PLUS ........SHORTS WILL BE CRUSHED
  • JACKPOT IN MAKING !!!!!!!!!!!BUY BUY BUY